In partnership with
November 14, 2025
Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Congress reopened the government by putting most hemp THC products on a one-year clock, and the early reactions tell you how fractured the landscape already is. Texas signals defiance, Ohio floats selective compliance, veterans’ groups warn about research setbacks, and national retailers now sit between federal statute and local demand. Our emergency episode of The Hybrid with Pam Epstein breaks down how shutdown politics delivered this rider and what dealmaking still remains for an industry that suddenly has fixed time on the board.
Today’s edition is supported by The Daily Upside, The Marketing Millennials, and the final day to use code POLICYDECODED20 for discounted access to IgniteIt’s Cannabis Capital & Policy Summit in Washington, D.C. this coming Monday.
🥤 Hemp ban starts a 365-day fight over who controls THC
🌵 States test how far they can ignore Washington
🎖️ Veterans and regulators scramble to redraw their playbooks
Catch that Pats game last night? Enjoy your weekend.
Wall Street’s Morning Edge.
Investing isn’t about chasing headlines — it’s about clarity. In a world of hype and hot takes, The Daily Upside delivers real value: sharp, trustworthy insights on markets, business, and the economy, written by former bankers and seasoned financial journalists.
That’s why over 1 million investors — from Wall Street pros to Main Street portfolio managers — start their day with The Daily Upside.
Invest better. Read The Daily Upside.
Start here — the day’s most important development, decoded for impact.
Hemp Ban Starts A 365 Day Fight Over Who Owns THC
📌 What Happened: Congress reopened the federal government with a rider that rewrites the hemp playbook by capping total THC at 0.4 milligrams per package and treating most hemp derived cannabinoids as contraband rather than a loophole to be managed. Newsweek walks through the fine print and lands on an estimate that roughly 95% percent of existing hemp products disappear under the new standard, along with about 1.5 billion dollars in annual tax revenue for states that leaned into intoxicating hemp. The U.S. Hemp Roundtable responded within hours, telling members that the harmful language was fueled by misinformation and that they now have 365 days to replace prohibition with a federal framework built around GMP, labeling, synthetic THC bans, and strict age gates. While that campaign kicks off, MJBizDaily is already asking what happens if states refuse to enforce the new ban, pointing to Ohio and other markets where hemp beverages are mainstream and no one plans to start arresting teenage clerks for stocking seltzers. On the ground, Axios Chicago shows Illinois brewers staring at a financial cliff after building THC drink lines that now look like stranded assets, and Marijuana Moment reports that the Veterans of Foreign Wars is warning Congress it may have just slammed the door on research veterans are desperate to see move forward.
💡 Why It Matters: The hemp ban functions as a live power struggle over who controls THC in the United States for the next decade, far bigger than a cleanup of gas station gummies. Regulated cannabis operators and alcohol distributors see a chance to shove intoxicating hemp into the same cage they live in, while many hemp brands feel like they got ambushed in a shutdown deal that never allowed for public hearings on what responsible regulation should look like. States are already drifting into distinct camps, with some likely to track federal language and others, including Texas and parts of the Midwest, signaling they will continue to treat hemp THC as legal under state law and leave federal agents to sort out the conflict on their own. Banks, insurers, and national retailers now sit in the middle, forced to pick between black letter federal law and very real local markets, which is often where business models live or die long before a raid or a lawsuit arrives. We have covered this story every day this week because the statute keeps revealing new fault lines and reactions long after the President signed it. Each new brief surfaces another angle on how this language will be used, who plans to ignore it, and how future fights over cannabinoids are likely to unfold.
🧠 THC Group Take: When I worked in the Senate, I cut my policy teeth on health care. My boss, the health care guru behind Romneycare, had a line he pulled out whenever we started dreaming up grand fixes. If you could wipe the board clean and design a health care system from scratch, you would never build the one we live with now. Our job was to take that disjointed system as the canvas we have and keep asking one question about every bill, amendment, and regulation. Is the system even a little better or does it make it worse? That little talk kept us from trying to rewrite the universe in one motion and forced us to focus on the plate in front of us. Access. Cost containment. Payment systems.
That same mindset fits this hemp moment. We do not have a coherent national THC policy. What we have is a pile of half finished frameworks for hemp, marijuana, supplements, food, and drugs that nobody built to work together. Congress just stapled a new set of THC rules onto a spending bill and called it governing, and now regulators, courts, and markets have to decide how much damage gets locked in and how much can be bent into something closer to a functional system. The new language hands agencies a definition set for intoxicating cannabinoids, chemical conversions, and trace limits, and those words will creep into every rulemaking on beverages, edibles, vapes, and lab standards whether anyone in the market feels ready for that or not. From a regulator’s chair the real limiter is capacity, because there is no world where federal agents chase every hemp drink in every fridge, so the hard choices land with state tax departments, local boards of health, compliance teams, banks, and national retailers.
Executives who read this as a narrow hemp problem are missing the larger story. Congress just moved a big chess piece. This move can wipe out an entire product class with a single rider and almost no debate, and that kind of move now hangs over high dose edibles, novel cannabinoids, and aggressive state level beverage carve outs. What is your next move in response to that? Remember…the canvas we have isn’t blank. Can we make it a little better?
The smart play over the next twelve months is a two track strategy. Push hard for a regulated national hemp framework that focuses on age gates, potency, and quality, while quietly moving the riskiest THC revenue into channels and structures that stand a chance if the prohibition arrives exactly as written. Having built a state system from scratch, this looks familiar to me. A statute thrown together in a hurry, a scramble to retrofit real markets to vague language, and a long year coming where the people who keep their head, keep asking whether each implementation step makes things better or worse, and keep their hands dirty in the real world of distribution and enforcement are the ones who end up owning whatever THC landscape exists in 2026.
Fast-moving headlines, flagged for what matters.
MJBizDaily walks through the uncomfortable question now hanging over the new federal hemp THC ban, which is what happens if states and retailers simply refuse to treat it as real. Ohio is already a live test, with Governor Mike DeWine’s own hemp crackdown tied up in court while lawmakers explore folding hemp THC into the existing marijuana regime instead of marching in step with Washington. Legal scholars quoted in the piece point out that the federal government never had the manpower to shut down state legal cannabis, so it is even less likely to send agents after every gas station and grocery store selling hemp drinks in fifty states. Even hard-line Republicans like Ohio House Speaker Matt Huffman admit the state is not going to start cuffing teenage clerks over hemp seltzers, which exposes the gap between tough talk in DC and the on-the-ground reality in places where these products are now mainstream. Executives should treat this as a preview of a two-tier map where some states align with the new federal ban and others quietly run their own rules, and the real risk comes from confused banks, insurers, and national retailers rather than DEA raids. (MJBizDaily)
Cannabis Business Times walks through how Trump’s shutdown deal did more than reopen the government, it hard-codes a federal framework that will recriminalize most intoxicating hemp products in November 2026 and gives FDA ninety days to sort out which cannabinoids count as natural, synthetic, or intoxicating. The U.S. Hemp Roundtable is treating it as a near extinction event and is trying to pivot the next year into a campaign for a national regime built around age gating, packaging, and real testing, rather than a simple kill shot. NCIA leans into the one plant argument and uses the moment to push for descheduling or rescheduling with a unified standard that treats hemp and marijuana as one cannabinoid system instead of rival categories. ATACH and several executives, including NewLake Capital and Flowhub’s Kyle Sherman, back the bill as overdue cleanup that preserves nonintoxicating hemp and forces high potency products into state cannabis channels. The divide between trade groups and operators on this one will shape the next farm bill, state copycat laws, and any serious federal cannabis negotiations, and executives need to decide quickly whether their brands live on the prohibition, integration, or reform side of that line. (Cannabis Business Times)
Newsweek walks through the fine print of Trump’s hemp crackdown and lands on a simple conclusion: any product with more than 0.4 milligrams of total THC per package disappears, along with nearly every item built on delta-8, delta-10, HHC, or THCA. Modeling from the U.S. Hemp Roundtable pegs the impact at roughly ninety five percent of existing hemp products and an estimated one and a half billion dollars in lost tax revenue, which turns this into a direct hit on state budgets that leaned into intoxicating hemp. Experts quoted in the story split sharply, with Jonathan Caulkins praising the change as overdue containment and Kevin Boehnke warning that recriminalization will push these products into dirtier illicit channels and replay familiar drug war mistakes. The product list has now become a blueprint for how Congress and eventually FDA draw lines around intoxicating cannabinoids, synthetic conversions from CBD, and acceptable trace levels once broader cannabis reform becomes unavoidable. Any beverage, edible, or vape team using hemp THC needs a plan that moves beyond legal creativity and treats dose and chemistry caps as federal facts that will bleed into state rules, insurance underwriting, and valuation models. (Newsweek)
Economist Robin Goldstein argues that Trump’s new federal THC hemp ban barely touches daily life in Texas, because Governor Abbott already signed a state framework that explicitly legalizes intoxicating hemp products and protects an industry worth more than four and a half billion dollars. Congress drew its new red line at 0.4 milligrams of total THC per package, which would wipe out nearly all current hemp vapes, flower, gummies, and drinks, yet Texas law continues to green-light those items and local police answer to Austin, not Washington. Texas now sits in the same category as California and Colorado, a state running a large THC market in plain sight of a federal statute that still calls it illegal. The real pinch point comes from banks, insurers, landlords, and national retailers trying to reconcile a stable Texas statute with a suddenly hostile federal backdrop. Anyone operating in conservative states should study this as a live example of what happens when a Republican governor openly owns the conflict with federal cannabis policy instead of backing away from it. (Houston Chronicle)
Marijuana Moment details how Veterans of Foreign Wars leadership just warned Congress that the new federal hemp THC ban could make it almost impossible for VA hospitals and researchers to study hemp derived cannabinoids at the same time veterans are begging for alternatives to benzos and opioids. VFW officials Carol Whitmore and Dan West describe veterans cycling through sedatives and psychoactive meds that leave them numb, dependent, or barely functional, and say early data on certain hemp compounds justifies more research, not a freeze. Their letter makes clear they are not looking for a free for all and instead asks for guardrails that protect the public while preserving research pathways and veteran owned hemp businesses that already use age gates and real testing. The politics look especially rough given that the spending bill both recriminalizes most consumable hemp products next year and strips out language that would have allowed VA doctors to recommend state legal medical cannabis. Any company tied to cannabinoid wellness or beverages should view veterans’ groups as potential partners in pushing for a research safe harbor, because that coalition can cut through generic protect the kids talking points in a way industry trade groups rarely can. (Marijuana Moment)
Three months after President Trump told reporters he would decide on marijuana rescheduling within weeks, a White House spokesperson now says the Schedule III review is still moving through internal policy and legal vetting. The process tracks back to the 2024 notice of proposed rulemaking to move cannabis from Schedule I to Schedule III, which triggered a round of hearings and written comments that have not yet produced a final rule. Trump continues to talk up rescheduling, banking reform, and even Florida adult-use, while also leaning hard into child protection rhetoric that keeps everyone guessing about where he lands. Senate voices like Ron Wyden are already publicly frustrated with the slow pace, and Berny Moreno is treating rescheduling as a necessary step toward a workable cannabis banking framework. Anyone planning serious multi-state expansion needs one scenario where rescheduling lands late and messy with litigation and another where the thing drifts into the next election cycle and keeps 280E and banking friction fully baked into deal terms. (Marijuana Moment)
Virginia Business reports that AYR Wellness’ foreclosure auction has left the Shenandoah Valley’s long delayed medical marijuana permit in a fresh round of uncertainty, even as creditors create a “New AYR” to carry on operations. The Virginia Cannabis Control Authority had only just awarded AYR Virginia a conditional pharmaceutical processor permit for Health Service Area 1 after a chaotic lottery process that produced a 33-way tie and multiple lawsuits from losing applicants. Now the winning assets sit with senior noteholders who must seek regulatory approval to transfer ownership and the permit, a process local counsel says will take time rather than accelerate access for patients around Charlottesville, Fredericksburg, and the Valley. Critics are already arguing that the state picked a financially overextended MSO via random-number drawing, which leaves thirty-two other would-be operators watching an essential regional license stall while AYR’s restructuring plays out. Anyone eyeing Virginia’s expected adult-use launch should read this as a reminder that debt-heavy counterparties and clumsy procurement design can freeze an entire region’s cannabis access long before the first retail application window ever opens. (Virginia Business)
Marijuana Moment reports that Governor Josh Shapiro’s push to legalize adult-use cannabis through the state budget died in negotiations, but House and Senate champions insist the issue jumps to the front of the 2026 agenda. House Health Chair Dan Frankel sounds pessimistic about the Republican controlled Senate’s vote count, while Representative Emily Kinkead points straight at the state’s revenue gap as the forcing mechanism that keeps cannabis on the table. Representative Rick Krajewski wants to revive his House-passed model built around state run stores or take up a Senate alternative, and Senator Sharif Street expects cannabis to sit near the top of next year’s negotiations as leaders hunt for revenue sources that do not involve income or sales tax hikes. Senator Dan Laughlin’s proposal to create a separate Cannabis Control Board that oversees medical, intoxicating hemp, and eventual adult-use gives lawmakers a lower risk infrastructure-first option that still moves policy forward. Anyone holding assets in Ohio, New York, or New Jersey should assume Pennsylvania joins the corridor and focus less on whether legalization happens and more on which retail model comes out of a late night conference committee. (Marijuana Moment)
SFGATE outlines how the Trump administration’s July 2025 immigration raid on Glass House Brands has cost the company more than twenty six million dollars in lost revenue, cut its harvest by over one hundred thousand pounds of dried cannabis, and left one worker dead after a fall from a greenhouse roof. Federal agents arrested more than three hundred sixty workers and reported finding fourteen minors, which triggered a state investigation into underage labor, while Glass House says it never knowingly violated labor laws and has not been charged. Immigrant rights advocates accuse the company of walking back promises to fund legal support, and deported workers describe being rushed through the process without lawyers while wage theft complaints stack up. Management has shifted to automation, tighter worker verification, and relationship repair with federal agencies, and the public markets appear comfortable with that trade since the company’s valuation now tops five hundred forty million dollars. Immigration enforcement has now joined RICO, 280E, and diversion on the short list of risks that can hit a licensed operator overnight, so investors need to treat farm labor contractors and political exposure as core underwriting questions, not afterthoughts. (SFGATE)
Business of Cannabis lays out how Portugal became the medical cannabis doorway into Europe by serving as a GMP washer for GACP growers from Canada, Colombia, Thailand, and other producing regions, with exports to Germany alone topping twenty seven thousand kilograms in the first half of 2025. That model is suddenly under pressure as suppliers run the math on one euro per gram processing costs against wholesale pricing near three euros per gram and decide it is cheaper to build their own EU GMP facilities at home. Operation Erva Daninha then forced Infarmed to crack down on documentation abuse, stretching export permit approvals from roughly a month to well over seventy days and turning a reliable corridor into a bottleneck that ages product on the tarmac. Executives quoted in the story describe cash locked up for months while wholesalers grow reluctant to take older inventory, which pushes global suppliers toward the Czech Republic, North Macedonia, and fully integrated models that send finished product straight into pharmacies. Anyone mapping a European export strategy has to stop treating Portugal as the default gateway and start modeling scenarios where German oversupply, slower regulators, and new hubs scramble both timing and margin. (Business of Cannabis)
Capitol Weekly lays out how Assemblymember Matt Haney’s AB 564 freezes California’s cannabis excise tax at fifteen percent until June 2028, blocking a scheduled hike to as high as nineteen percent that was meant to protect youth, environmental, and equity programs funded by Proposition 64. Wholesale prices have fallen since 2021 even as demand ticked up, and retailers describe a bare-knuckle price war where oversupply and stacked local taxes push margins to the floor while unlicensed operators still own roughly sixty percent of the market. Labor unions back the pause because every failed retailer takes union hours, healthcare, and retirement contributions with it, and they understand that squeezing a declining legal market harder just pushes consumers back to untaxed, untested supply. Youth and community advocates see the move as a broken promise layered on top of the earlier decision to scrap the cultivation tax, and they are already counting a projected one hundred thirty five million dollars in lost revenue next year alone. The deeper lesson for other states is simple: tying social programs directly to a fragile cannabis tax base looks clean in a ballot pamphlet but becomes a permanent political fight when markets mature, prices fall, and lawmakers have to choose between keeping shops alive and keeping grants whole. (Capitol Weekly)
The best marketing ideas come from marketers who live it.
That’s what this newsletter delivers.
The Marketing Millennials is a look inside what’s working right now for other marketers. No theory. No fluff. Just real insights and ideas you can actually use—from marketers who’ve been there, done that, and are sharing the playbook.
Every newsletter is written by Daniel Murray, a marketer obsessed with what goes into great marketing. Expect fresh takes, hot topics, and the kind of stuff you’ll want to steal for your next campaign.
Because marketing shouldn’t feel like guesswork. And you shouldn’t have to dig for the good stuff.
From the hearing room to the comment section — we’re watching it all.
⚖️ Florida Governor Ron DeSantis is still telling voters Colorado’s legalization experiment failed while Colorado Governor Jared Polis keeps waving a decade of tax revenue and youth use data in his face, and that split is now part of the 2026 campaign script. Every time that argument goes national, lawmakers are forced to pick a lane between ten years of Colorado numbers and a narrative that falls apart the moment someone opens a budget spreadsheet. (Marijuana Moment)
💻 Sweed is paying ethical hackers up to two thousand dollars to poke holes in its retail tech stack, which quietly turns cybersecurity into part of the cannabis compliance playbook instead of a back-office afterthought. Once point of sale and e-commerce vendors are running bug bounties, regulators and plaintiffs will treat data breaches as avoidable failures, not bad luck. (High Times)
🍺 Lakefront Brewery just launched “High Jinx,” a ten milligram delta-9 THC lemonade in Milwaukee, fully aware Congress has started the clock on a federal hemp THC ban that could wipe it off shelves in a year. Craft brewers are basically saying they would rather race the sunset than wait quietly for regulators to decide whether their lifeline category lives or dies. (Milwaukee Record)
🌲 A key witness in Maine’s sprawling illegal grow case says he nearly walked former Governor Paul LePage through the very Farmington facility now at the center of a federal trial, and admits he probably could have arranged a visit from Governor Janet Mills as well. The scheme already took down local cops and a prosecutor, and now it brushes against two governors, which is exactly how one rogue operation can stain an entire state’s cannabis narrative. (Bangor Daily News)